Milestone Pharmaceuticals Inc. · NASDAQ:MIST

Propel Bio Management, LLC reported a 9.90% stake in Milestone Pharmaceuticals Inc. (Schedule 13G)

Event Jul 11, 2025 · Filed Dec 23, 2025

Propel Bio Management, LLC reported a 9.90% stake in Milestone Pharmaceuticals Inc., 8,861,186 shares, as a passive investor on Jul 11, 2025. Filed Dec 23, 2025 (Schedule 13G).

Stake
9.90%
Shares
8,861,186
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Propel Bio Management, LLC9.90%8,861,186
Leen Kawas9.90%8,861,186
Richard Kayne9.90%8,861,186
Propel Bio Partners LLC9.90%8,861,186

Source

View original at SEC

Related